Aarey Drugs & Pharmaceuticals Limited — Important, 30-07-2025: Updates

AAREYDRUGS has refiled its audited annual financial results for the year ended March 31, 2025. This revision corrects an inadvertent clerical error in the paid-up share capital disclosure. The company confirms no other changes to the previously submitted results. Auditors issued an unmodified opinion, noting that new plant and machinery is not yet depreciated as it's not operational, and some debtor/creditor balances are unconfirmed but relied upon management representations. This ensures accurate financial reporting for shareholders.